TechnologyConsumerInvestor's Business Daily · 8h ago

Stock Market Today: Dow Up, Nasdaq Rallies; Sandisk Surges As This Biotech Play Tests Entry (Live Coverage)

AMDAMZNCATNVDA

Latest in Biotech · updated 20:26 ET

M

City Therapeutics raises $230M in upsized Nasdaq IPO

MarketsIPOs & M&A Investing.com · 4h ago

REGN

Strong Dupixent Trajectory Anchors Regeneron Pharmaceuticals’ (REGN) Solid Financial Results

HealthcareEarnings Insider Monkey · 7h ago · REGN

IMUX

Immunic Names Jaa Roberson Chief People Officer

Healthcare Nasdaq · 7h ago · IMUX

H

Evaxion stock surges on 3-year melanoma vaccine trial data

Healthcare Investing.com · 8h ago

M

Why is Silence Therapeutics stock up 125% today?

Markets Investing.com · 10h ago

M

Silence Therapeutics stock soars 125% on Merck acquisition

MarketsIPOs & M&A Investing.com · 11h ago

M

Veradermics stock surges as hair loss drug meets Phase 3 goals

Markets Investing.com · 11h ago

Zacks.com featured highlights include Halozyme Therapeutics, GigaCloud Technology, Lindblad Expeditions, Permian Resources and Chevron

EnergyTechnology Zacks · 12h ago · CVXGCTHALO

APA

The Zacks Analyst Blog Highlights Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics

EnergyHealthcare Zacks · 12h ago · APACORTHALO

H

Seraxis Names Former FDA Medical Officer Patricia Beaston As Chief Medical Officer Ahead Of Merger

HealthcareIPOs & M&A Nasdaq · 12h ago

QQQ

Vertex Pharmaceuticals (VRTX) Sees $11.6 Million in Net ETF Buying on Thursday

Healthcare GuruFocus.com · 13h ago · QQQVRTX

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

TechnologyHealthcareEarnings GlobeNewswire · 13h ago · AMDEYPT

M

Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.

MarketsEarnings Nasdaq · Oct 18

ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology

Healthcare Business Wire · Oct 18 · NTRA

CRSP

Where Will CRISPR Therapeutics Stock Be in 2030?

HealthcareTechnology Motley Fool · Oct 18 · CRSPNVDA

Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?

Healthcare Motley Fool · Oct 18 · MRNAPFE

Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings

Consumer Simply Wall St. · Oct 17 · AMZN

Revolution Medicines Stock In Focus After EU Drug Backing

Healthcare Simply Wall St. · Oct 17 · RVMD

Phase 3 Cancer Vaccine Success Could Change The Case For Moderna Stock

Healthcare Simply Wall St. · Oct 17 · MRKMRNA

ALNY

Jefferies Highlights Top Mid-Cap Biotech Stocks Ahead of Earnings

HealthcareEarnings Investing.com · Oct 16 · ALNYJEFRVMD

Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests

Healthcare GlobeNewswire · Oct 16 · AGHILMN

Global Proteomic Biomarker Analytics Market: Five-Year Forecast by Application, Technology, Product, and End User | Double-Digit Growth Boosts Cancer Diagnostics and Drug Discovery

Healthcare GlobeNewswire · Oct 16 · DHRILMNTMO

VSTM Stock Clocks Best Day In 11 Months After Positive Cancer Drug Trial Update And Multiple Price-Target Hikes

Healthcare Stocktwits · Oct 15 · RVMDVSTM

Revolution Medicines' Pancreatic Cancer Drug Gets EU Panel Recommendation

Healthcare MT Newswires · Oct 15 · RVMD

Iambic, an AI drug discovery specialist, banks $150M in an IPO

HealthcareIPOs & M&A BioPharma Dive · Oct 14 · ILMN

Verastem Gets a New CEO, $250M, and a Shot at Another Cancer Drug

Healthcare Barrons.com · Oct 14 · MRKMRNAPFE

Does NewAmsterdam Pharma’s (NAMS) Genotype-Targeted SPINOZA Trial Reframe Obicetrapib’s Long-Term Alzheimer’s Strategy?

Healthcare Simply Wall St. · Oct 13 · NAMS

Natera and TransCode Therapeutics to Collaborate on Phase 2a Trial of TTX-MC138 in Colorectal Cancer

Healthcare Business Wire · Oct 13 · NTRARNAZ

Is 10x Genomics (TXG) Using Its Fred Hutch Oncology Alliance To Redefine Its Clinical Moat?

Healthcare Simply Wall St. · Oct 09 · TXG

RBC Cuts Price Target on NewAmsterdam Pharma to $42 From $50, Keeps Outperform, Speculative Risk

HealthcareIndustrialsAnalyst Moves MT Newswires · Oct 05 · NAMSRBC

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Healthcare GlobeNewswire · Oct 02 · NAMS

NewAmsterdam Pharma Doses First Participant in Phase 2b Trial for Preclinical Alzheimer's Disease

Healthcare MT Newswires · Sep 29 · NAMS

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

Healthcare GlobeNewswire · Sep 29 · NAMS

NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties?

Healthcare Insider Monkey · Sep 22 · NAMS

Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look

Healthcare Investor's Business Daily · Sep 22 · CAI

Headlines link to their publishers. Stock-market stories only. Top News ranks stories by how widely they are covered (near-duplicate headlines are grouped), recency and whether they involve major companies. Sectors come from the GICS sector of the companies a story names (a story can have more than one); stories that name no company are tagged from keywords. Sources: CNBC, MarketWatch, Nasdaq, Investing.com, BBC Business, OilPrice.com (public RSS) and Yahoo Finance. Tags are automatic and can be wrong. MTD = month-to-date return of each model's current picks (hypothetical, before costs).

coteau

Hypothetical research for education, not investment advice. Data: Yahoo Finance (via yfinance, delayed), SEC EDGAR.

DisclaimerTermsPrivacyGlossaryTrack recordData status